CAMP4 Therapeutics logo
CAMP4 Therapeutics
CAMP | NASDAQ
Chart Builder DCF Calculator
$3.86
+$0.06 (+1.58%)
At close: Nov 16, 2026, 4:00 PM ET
$3.62
-$0.24 (-6.11%)
After-hours: Nov 16, 2026, 7:52 PM ET

CAMP4 Therapeutics Company Profile

Company profile explained

Company Profile

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Key Executives

Name Position
Joshua Mandel-Brehm Chief Executive Officer, President & Director
Kelly Gold Chief Financial Officer
Michelle Gates Senior Vice President & Chief People Officer
Alla Sigova Senior Vice President of Platform
Caleb Moore Chief Business Operations Officer
Daniel Tardiff Chief Scientific Officer
Leonard I. Zon Founder & Chairman of Scientific Advisory Board
Richard A. Young Founder & Independent Director
Satya Kuchimanchi Senior Vice President of Technical Operations
Yuri Maricich Chief Medical Officer

Latest SEC Filings

Date Type Title
Sep 28, 2026 8-K Current Report
Sep 02, 2026 4 Filing
Aug 31, 2026 SC 13D/A [Amend] Filing
Aug 31, 2026 4 Filing
Aug 26, 2026 4 Filing
Aug 21, 2026 4 Filing
Aug 19, 2026 4 Filing
Aug 19, 2026 SC 13D/A [Amend] Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2026 10-Q Quarterly Report
View All SEC Filings ➞
CAMP4 Therapeutics
CAMP4 Therapeutics logo
Country United States
IPO Date Oct 11, 2024
Industry Biotechnology
Sector Healthcare
Employees 48
CEO Joshua Mandel-Brehm

Contact Details

One Kendall Square Bldg 1400 West, 3rd Floor Cambridge, Massachusetts 02139 United States

Stock Details

Ticker Symbol CAMP
Exchange NASDAQ
Fiscal Year March - February
Reporting Currency USD
CIK Code 0001736730
CUSIP Number 13463J101
ISIN Number US13463J1016
SIC Code 3663

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.